Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Berman

Showing results (421-430 of 459) with videos related to

Pageof 46
Sort By:
Cytokine|February 24, 2009
TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cellsHua-Xin Gao, Sean R Campbell, Linda C Burkly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1996
Humanization of an anti-lymphocyte function-associated antigen (LFA)-1 monoclonal antibody and reengineering of the humanized antibody for binding to rhesus LFA-1W A Werther, T N Gonzalez, S J O'Connor, et al.
Journal of Virology|August 21, 2025
Parallel evolution of the elite neutralizer phenotype in divergent HIV-1 cladesKathryn A Mesa, Sophia W Li, Jennie M Hutchinson, et al.
Nature|June 14, 1990
Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160P W Berman, T J Gregory, L Riddle, et al.
Viruses|November 17, 2020
Methamphetamine Increases the Proportion of SIV-Infected Microglia/Macrophages, Alters Metabolic Pathways, and Elevates Cell Death Pathways: A Single-Cell AnalysisMeng Niu, Brenda Morsey, Benjamin G Lamberty, et al.
Science (New York, N.Y.)|July 11, 1986
Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoproteinL A Lasky, J E Groopman, C W Fennie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in metastatic and locally advanced breast cancerJennifer A Low, Suparna B Wedam, James J Lee, et al.
AIDS (London, England)|March 26, 2009
Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imagingMichelle Floris-Moore, Zahi A Fayad, Joan W Berman, et al.
Journal of Leukocyte Biology|June 25, 2020
Treatment with buprenorphine prior to EcoHIV infection of mice prevents the development of neurocognitive impairmentMatias Jaureguiberry-Bravo, Jennifer Kelschenbach, Aniella Murphy, et al.
AIDS Research and Human Retroviruses|February 24, 1999
HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation GroupG J Gorse, L Corey, G B Patel, et al.
Pageof 46

Showing results (421-430 of 459) with videos related to

Sort By:
Pageof 46
Cytokine|February 24, 2009
TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cellsHua-Xin Gao, Sean R Campbell, Linda C Burkly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1996
Humanization of an anti-lymphocyte function-associated antigen (LFA)-1 monoclonal antibody and reengineering of the humanized antibody for binding to rhesus LFA-1W A Werther, T N Gonzalez, S J O'Connor, et al.
Journal of Virology|August 21, 2025
Parallel evolution of the elite neutralizer phenotype in divergent HIV-1 cladesKathryn A Mesa, Sophia W Li, Jennie M Hutchinson, et al.
Nature|June 14, 1990
Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160P W Berman, T J Gregory, L Riddle, et al.
Viruses|November 17, 2020
Methamphetamine Increases the Proportion of SIV-Infected Microglia/Macrophages, Alters Metabolic Pathways, and Elevates Cell Death Pathways: A Single-Cell AnalysisMeng Niu, Brenda Morsey, Benjamin G Lamberty, et al.
Science (New York, N.Y.)|July 11, 1986
Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoproteinL A Lasky, J E Groopman, C W Fennie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in metastatic and locally advanced breast cancerJennifer A Low, Suparna B Wedam, James J Lee, et al.
AIDS (London, England)|March 26, 2009
Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imagingMichelle Floris-Moore, Zahi A Fayad, Joan W Berman, et al.
Journal of Leukocyte Biology|June 25, 2020
Treatment with buprenorphine prior to EcoHIV infection of mice prevents the development of neurocognitive impairmentMatias Jaureguiberry-Bravo, Jennifer Kelschenbach, Aniella Murphy, et al.
AIDS Research and Human Retroviruses|February 24, 1999
HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation GroupG J Gorse, L Corey, G B Patel, et al.
Pageof 46